Date | 22 July 2020 | – 13 April 2023
---|---|
Location | China |
Cause | COVID-19 pandemic in mainland China |
Target | Immunization against COVID-19 |
Organized by | Joint Prevention and Control Mechanism in Response to the COVID-19 Pandemic of the State Council (headquartered at National Health Commission) |
Participants | 3,491,077,000[1] (total doses administered) |
Outcome | 1,310,292,000[1] (total vaccinated) 1,276,760,000[1] (fully vaccinated) |
Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.
As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose.[2]